461 related articles for article (PubMed ID: 32399646)
1. Molecular and cellular mechanisms underlying brain metastasis of breast cancer.
Hosonaga M; Saya H; Arima Y
Cancer Metastasis Rev; 2020 Sep; 39(3):711-720. PubMed ID: 32399646
[TBL] [Abstract][Full Text] [Related]
2. Laminin I mediates resistance to lapatinib in HER2-positive brain metastatic breast cancer cells in vitro.
Gurung SK; Shevde LA; Rao SS
Biochem Biophys Res Commun; 2024 Aug; 720():150142. PubMed ID: 38788545
[TBL] [Abstract][Full Text] [Related]
3. Astrocyte-induced Reelin expression drives proliferation of Her2
Jandial R; Choy C; Levy DM; Chen MY; Ansari KI
Clin Exp Metastasis; 2017 Feb; 34(2):185-196. PubMed ID: 28210910
[TBL] [Abstract][Full Text] [Related]
4. Pazopanib inhibits the activation of PDGFRβ-expressing astrocytes in the brain metastatic microenvironment of breast cancer cells.
Gril B; Palmieri D; Qian Y; Anwar T; Liewehr DJ; Steinberg SM; Andreu Z; Masana D; Fernández P; Steeg PS; Vidal-Vanaclocha F
Am J Pathol; 2013 Jun; 182(6):2368-79. PubMed ID: 23583652
[TBL] [Abstract][Full Text] [Related]
5. Expression of CD24 is associated with HER2 expression and supports HER2-Akt signaling in HER2-positive breast cancer cells.
Hosonaga M; Arima Y; Sugihara E; Kohno N; Saya H
Cancer Sci; 2014 Jul; 105(7):779-87. PubMed ID: 24754246
[TBL] [Abstract][Full Text] [Related]
6. EGFR and HER2 signaling in breast cancer brain metastasis.
Sirkisoon SR; Carpenter RL; Rimkus T; Miller L; Metheny-Barlow L; Lo HW
Front Biosci (Elite Ed); 2016 Jan; 8(2):245-63. PubMed ID: 26709660
[TBL] [Abstract][Full Text] [Related]
7. Cancer-stromal cell interactions in breast cancer brain metastases induce glycocalyx-mediated resistance to HER2-targeting therapies.
Goyette MA; Stevens LE; DePinho CR; Seehawer M; Nishida J; Li Z; Wilde CM; Li R; Qiu X; Pyke AL; Zhao S; Lim K; Tender GS; Northey JJ; Riley NM; Long HW; Bertozzi CR; Weaver VM; Polyak K
Proc Natl Acad Sci U S A; 2024 May; 121(20):e2322688121. PubMed ID: 38709925
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen suppresses brain metastasis of estrogen receptor-deficient breast cancer by skewing microglia polarization and enhancing their immune functions.
Wu SY; Sharma S; Wu K; Tyagi A; Zhao D; Deshpande RP; Watabe K
Breast Cancer Res; 2021 Mar; 23(1):35. PubMed ID: 33736709
[TBL] [Abstract][Full Text] [Related]
9. [Brain metastasis of breast tumors and blood brain barrier].
Diéras V; Pierga JY
Bull Cancer; 2011 Apr; 98(4):385-9. PubMed ID: 21527366
[TBL] [Abstract][Full Text] [Related]
10. Receptor change-clinicopathologic analysis of matched pairs of primary and cerebral metastatic breast cancer.
Bachmann C; Grischke EM; Staebler A; Schittenhelm J; Wallwiener D
J Cancer Res Clin Oncol; 2013 Nov; 139(11):1909-16. PubMed ID: 24037487
[TBL] [Abstract][Full Text] [Related]
11. Primary and secondary distant metastatic breast cancer: two sides of the same coin.
Güth U; Magaton I; Huang DJ; Fisher R; Schötzau A; Vetter M
Breast; 2014 Feb; 23(1):26-32. PubMed ID: 24215983
[TBL] [Abstract][Full Text] [Related]
12. Targeting Autophagy in Breast Cancer.
Cocco S; Leone A; Piezzo M; Caputo R; Di Lauro V; Di Rella F; Fusco G; Capozzi M; Gioia GD; Budillon A; De Laurentiis M
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105796
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer subtype as a predictor for outcomes and control in the setting of brain metastases treated with stereotactic radiosurgery.
Grubb CS; Jani A; Wu CC; Saad S; Qureshi YH; Nanda T; Yaeh A; Rozenblat T; Sisti MB; Bruce JN; McKhann GM; Sheth SA; Lesser J; Cheng SK; Isaacson SR; Lassman AB; Connolly EP; Wang TJ
J Neurooncol; 2016 Mar; 127(1):103-10. PubMed ID: 26615564
[TBL] [Abstract][Full Text] [Related]
14. Brain metastases in HER2-positive breast cancer: the evolving role of lapatinib.
Tomasello G; Bedard PL; de Azambuja E; Lossignol D; Devriendt D; Piccart-Gebhart MJ
Crit Rev Oncol Hematol; 2010 Aug; 75(2):110-21. PubMed ID: 20004109
[TBL] [Abstract][Full Text] [Related]
15. Developmental therapeutics for patients with breast cancer and central nervous system metastasis: current landscape and future perspectives.
Costa R; Carneiro BA; Wainwright DA; Santa-Maria CA; Kumthekar P; Chae YK; Gradishar WJ; Cristofanilli M; Giles FJ
Ann Oncol; 2017 Jan; 28(1):44-56. PubMed ID: 28177431
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2
Nagpal A; Redvers RP; Ling X; Ayton S; Fuentes M; Tavancheh E; Diala I; Lalani A; Loi S; David S; Anderson RL; Smith Y; Merino D; Denoyer D; Pouliot N
Breast Cancer Res; 2019 Aug; 21(1):94. PubMed ID: 31409375
[TBL] [Abstract][Full Text] [Related]
17. Neurotrophin-3 modulates breast cancer cells and the microenvironment to promote the growth of breast cancer brain metastasis.
Louie E; Chen XF; Coomes A; Ji K; Tsirka S; Chen EI
Oncogene; 2013 Aug; 32(35):4064-77. PubMed ID: 23001042
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen attenuates reactive astrocyte-induced brain metastasis and drug resistance through the IL-6/STAT3 signaling pathway.
Xu Y; Zhu Y; Yue Y; Pu S; Wu J; Lv Y; Du D
Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(12):1299-1305. PubMed ID: 33355355
[TBL] [Abstract][Full Text] [Related]
19. FABP7 is a key metabolic regulator in HER2+ breast cancer brain metastasis.
Cordero A; Kanojia D; Miska J; Panek WK; Xiao A; Han Y; Bonamici N; Zhou W; Xiao T; Wu M; Ahmed AU; Lesniak MS
Oncogene; 2019 Sep; 38(37):6445-6460. PubMed ID: 31324889
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and course of brain metastases in triple-negative breast cancer: comparison with human epidermal growth factor receptor 2-positive and other type at single institution in Korea.
Jang G; Lee SS; Ahn JH; Jung KH; Lee H; Gong G; Kim HH; Ahn SD; Son BH; Ahn SH; Kim SB
Breast Cancer Res Treat; 2011 Jul; 128(1):171-7. PubMed ID: 21519835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
